VEGFA and retinal detachment: Even though intravitreal injections of anti-VEGF molecules can circumvent most of the disadvantages of other administration routes, for angiogenesis-related posterior segment ocular afflictions, repeated weekly injections could potentially instigate the development of threatening complications such as haemorrhage and retinal detachment, and eventually cause blindness [39].